CNS Pharmaceuticals Q2 FY26 net loss widens 9% to $2.59 million year over yearPUBT·21 hours agoCNSP-8.91%
CNS Pharmaceuticals Announces Strategic Oncology-Neurology RealignmentTip Ranks·Jul 2 at 06:58 AMCNSP-8.91%
CNS Pharmaceuticals CFO, Steve O'Loughlin, Highlights Company's Recent $22.5M Financing in Virtual Investor "What This Means" Segment | CNSP Stock NewsStockTitan·Jun 8 at 12:15 AMCNSP-8.91%
CNS Pharmaceuticals CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company's Recent Strategic Transformation ProgressMorningStar·May 20 at 08:10 AMCNSP-8.91%IBB+0.49%
What's Going On With CNS Pharmaceuticals Stock On Wednesday?benzinga_article·May 6 at 08:51 AMCNSP-8.91%LABU+2.17%
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga_article·May 5 at 07:06 AMEMBC-2.66%BDRX-5.06%
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga_article·May 4 at 12:06 PMCNSP-8.91%MNDR-5.49%
Morning News Wrap-Up, 5/4/26: Today's Biggest Stock Market Stories!Tip Ranks·May 4 at 11:28 AMCNSP-8.91%BX-0.52%
Dow Falls Over 150 Points; Tyson Foods Posts Upbeat Earningsbenzinga_article·May 4 at 08:40 AMTSN-1.10%.DJI-0.04%
